2025 ACMT Annual Scientific Meeting | #ACMT2025

Dr. Maryann Amirshahi is a Professor of Emergency Medicine at Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center, where she specializes in toxicology, addiction care, and emergency medicine. She holds a PharmD and medical degree, alongside an MPH focusing on environmental and occupational health, and a PhD in pharmacology and public health. Dr. Amirshahi is board-certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology, and is a registered pharmacist with over a decade of practice. Nationally recognized, she serves on the Board of Directors for the American College of Medical Toxicology and as co-medical director of the National Capital Poison Center. With nearly 200 peer-reviewed publications, her research spans medication safety, drug shortages, addiction treatment, and prescription drug misuse.

Carl Baum, MD, FAAP, FACMT, is board-certified in Pediatric Emergency Medicine and in Medical Toxicology, and has over 25 years' experience in both subspecialties. He serves as attending physician in the Pediatric Emergency Department, and as Director of the state-funded Lead Poisoning and Regional Treatment Center. Nationally, Dr. Baum serves the following organizations: Executive Committee, Council on Children and Disasters, American Academy of Pediatrics, Medical Toxicology Subboard, American Board of Pediatrics/American Board of Emergency Medicine, National Biodefense Science Board, Administration for Strategic Preparedness & Response, US Department of Health and Human Services. In addition, he is a member of the International Society for Children's Health and the Environment.

Jeffrey Brent, MD, PhD, is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

Nick Buckley is Professor of Clinical Pharmacology and a practicing clinical toxicologist consulting at RPA and through all the Poisons Centres in Australia. He is best known internationally for being a co-founder of the SACTRC collaboration, a centre of clinical toxicology research excellence in Sri Lanka with a focus on agrochemical poisoning and snakebite. http://www.sactrc.org/. He is a past President of the Asia Pacific Association of Medical Toxicology. Nick is highly experienced in clinical epidemiology and research design. His research has attracted continuous project and program funding since 2002 and has resulted in an extensive publication record including 480+ peer reviewed journal articles and 25 book chapters. He has supervised or co-supervised over 20 higher degree students.

Dr. Rose Cairns is a Lecturer at the University of Sydney School of Pharmacy and Director of Research and Senior Poisons Specialist at the New South Wales Poisons Information Centre, based at the Children’s Hospital at Westmead. Her research focuses on clinical toxicology, toxicovigilance, pharmacovigilance, pharmaceutical misuse, severe adverse drug reactions, and deliberate self-poisoning, with the overarching goal of reducing harm from poisoning. Rose has led impactful studies on trends in poisoning and drug policy effects, including research on methotrexate poisoning that resulted in changes to product labeling and consumer information. She has also examined the impact of medicine up-scheduling on drug misuse, with recent work on codeine and alprazolam. Additionally, her research explores the role of Poisons Information Centres in optimizing healthcare outcomes, as well as geographical inequalities in poisoning risk and access to treatment, offering opportunities for collaborative projects and student research.

Dr. Stephanie Carreiro is an emergency medicine physician, medical toxicologist, and digital health researcher. She is a 2009 graduate of New York Medical College, and completed her emergency medicine residency in 2013 at Brown University.  She completed a medical toxicology fellowship in 2015, and recently received a PhD in Biomedical Sciences both at the University of Massachusetts. She is currently an Associate Professor, Director of the Tox(In)novation Lab, and Research Director in the Department of Emergency Medicine at University of Massachusetts Chan Medical School. Her current research program focuses on developing digital therapeutics for substance use disorder, understanding how patients use and engage with technology, and leveraging digital technology to promote health equity. She is the principal investigator multiple industry and federally funded research grants, including several awards from the National Institute on Drug Abuse and National Institute of Biomedical Imaging and Bioengineering. 

Dr. Carroll is the Program Director for the EMS Fellowship at Cooper University Hospital, where he focuses on advancing physician field response to bring bedside medical education into the prehospital setting. Dual board certified in Emergency Medicine and Emergency Medical Services, he is passionate about resident and prehospital provider education, addiction medicine, and the role of urban EMS in serving underserved populations. A former paramedic with nearly a decade of experience in the New York City 911 system, including recognition for his service on 9/11, Dr. Carroll earned his medical degree from Dartmouth Medical School and completed his emergency medicine residency and EMS fellowship at Cooper University Hospital. He has championed innovative EMS practices, including nontraditional transport models and training paramedics to use buprenorphine for opioid withdrawal in the field. Committed to advancing patient outcomes and redefining EMS as a critical component of the healthcare system, he is interested in academic, prehospital, and disaster medicine, extending his practice to diverse settings such as rural and austere environments, as well as cruise ship medicine.

Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA. She is currently located at Ochsner Medical Center in New Orleans, LA where she serves as the Emergency Medicine Residency Assistant Program Director and the Resident Medical Toxicology Rotation director. Professionally, she enjoys academics, perinatal toxicology, and health policy. She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

Neeraj Chhabra, MD, MSCR is an Emergency Physician and Medical Toxicologist based in Chicago, Illinois. He provides medical toxicology consulting services for the Illinois Poison Center and Cook County Health. Dr. Chhabra completed his fellowship in medical toxicology with the Toxikon Consortium in 2017 and his master’s degree in clinical research at Rush University Graduate College in 2020. His clinical focus is on the acute management of poisonings and overdose.

Dr. Culbreth joined the Toxicology Investigators Consortium/ACMT in May 2022. She received her PhD and MPH in epidemiology and biostatistics from Georgia State University. Her dissertation focused on the development of novel statistical methods to measure current and amount of substance use in a hybrid structural equation mixture model framework. She was an Assistant Professor in the College of Nursing and Health Professions at Georgia State University from 2019-2022, where she taught undergraduate and graduate-level research methods, healthcare leadership, and advanced statistical topics for pre-doctoral students. As ToxIC's Research Director, she leads new grant development and scientific dissemination through manuscripts and presentations, and enjoys working closely with clinical colleagues to advance medical toxicology research and practice.

Andrew Dawson is an Australian Clinical Pharmacologist and Toxicologist with a focus on translational clinical toxicology research to influence policy and clinical practice. He founded the Australian Hunter Area Toxicology Service in Newcastle in 1987, conducting pivotal research on interventions for deliberate self-harm, drug toxicity in overdose, and toxicity prediction. In 2004, he moved to Sri Lanka to establish the South Asian Clinical Toxicology Research Collaboration, which built sustainable research capacity to address pesticide-related self-harm and improve clinical care in resource-limited settings, contributing to a 50% reduction in Sri Lankan national suicide deaths. Returning to Australia in 2010, he served as Director of Clinical Toxicology at Royal Prince Alfred Hospital and Director of the New South Wales Poison Information Centre at the Children’s Hospital Westmead (until 2021). A Clinical Professor of Medicine at the University of Sydney and Adjunct Professor at the University of New South Wales, his current work focuses on institutional responses to patients with complex self-harm behaviors, substance use disorders, and evaluating the impact of regulatory changes on self-harm incidence.

Dr. John W. Downs, MD, MPH, is a medical toxicology faculty member at Virginia Commonwealth University (VCU) and a retired U.S. Army officer with over 20 years of distinguished service. A graduate of the Virginia Military Institute and the Uniformed Services University (USU), he completed residencies in internal medicine and occupational & environmental medicine, as well as a fellowship in medical toxicology at VCU. Dr. Downs has extensive military medical experience, including multiple deployments as a senior medical officer for special operations and infantry units in Iraq and Afghanistan, and leadership roles such as Chief of Preventive Medicine at Fort Campbell and Chief of Occupational & Environmental Medicine at Walter Reed during the COVID-19 pandemic. Board certified in internal medicine, occupational & environmental medicine, and medical toxicology, he also holds certifications as a Certified Public Health professional (CPH) and Diplomate of the American Board of Toxicology (DABT). A Fellow of the American College of Physicians and the American College of Occupational and Environmental Medicine, Dr. Downs has authored over 25 peer-reviewed publications and is a recipient of the Army Surgeon General’s 9A Proficiency Designation.

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Dr. William Eggleston is a Clinical Assistant Professor at Binghamton University and the Director of the Opioid Research Center for Central New York (ORCC-NY), where he leads multidisciplinary efforts to innovate treatment and prevention strategies for opioid use disorder. He holds a Doctor of Pharmacy degree from Wilkes University and completed a fellowship in clinical toxicology and emergency medicine at SUNY Upstate Medical University and the Upstate New York Poison Center. A member of the executive board of the New York State chapter of the American College of Clinical Pharmacy (ACCP) and an active contributor to the American Academy of Clinical Toxicology, he focuses on opioid-related harm reduction, drug-induced cardiac toxicity, and web-based education tools that promote interprofessional collaboration. At SUNY Upstate, he works with the inpatient toxicology consultation team and the Poison Center, providing toxicology consultations, advancing public health initiatives, and delivering public education.

Dr. Erickson is an emergency medicine physician at Mass General Brigham in Boston, MA. He is the Division Chief of Medical Toxicology in the Department of Emergency Medicine. He is a Full Professor at Harvard Medical School and the Harvard Humanitarian Initiative (HHI). He is a Professor Emeritus at the University of Illinois where he established the UIC Center for Global Health. His areas of expertise include CBRNE response and training, environmental toxicology, crisis in climate change, wastewater epidemiology, and acute injuries from global conflict settings such as Ukraine, Syria, Kosovo, Sudan, and Rwanda. Over the past 3 decades he had conducted numerous projects and deployments to Ukraine with NATO and International Medical Corps (IMC).

Alyssa joined the Toxicology Investigators Consortium/ACMT in November 2023. Alyssa earned her PhD in epidemiology from the University of Florida and her MSPH from the University of Miami. While at the University of Florida, Alyssa was trained in psychiatric epidemiology as a National Institute on Drug Abuse T32 Pre-Doctoral Fellow in the UF Substance Abuse Training Center in Public Health. In 2023, Alyssa was awarded the College on Problems of Drug Dependence’s Female Opioid-addiction Research and Clinical Experts (FORCE) Junior Investigator Award for her research addressing opioid use and non-medical use among middle and older adults.

Dr. Ana Ferrer Dufol holds a degree in Biochemistry and a Doctor of Medicine from the University of Zaragoza, where she was awarded the Extraordinary Prize for her doctorate. She is a specialist in Pathological and Forensic Anatomy and a graduate in Criminology and Clinical Toxicology from the Claude-Bernard University of Lyon (France). Since 1996, she has combined her role as a professor in the Area of Toxicology and Health Legislation at the University of Zaragoza with her position as Section Head of the Clinical Toxicology Unit at the University Clinical Hospital, a reference unit in Aragon. In addition, she is a member of the scientific committee of the Aragonese Food Safety Agency. Her professional expertise has enabled her to coordinate, for more than 11 years, a toxicovigilance program with the Ministry of Health to monitor cases of poisoning caused by chemical products in hospital emergency services. Her work has been published in international journals, particularly on toxic epidemics related to pesticide agents.

Charlotte Goldfine, MD is an emergency medicine physician and medical toxicologist at Brigham and Women’s Hospital (BWH). She is the course director for the Harvard-Affiliated Emergency Medicine Residency toxicology core rotation and the BWH site fellowship director for the Harvard Toxicology Fellowship. Her research is focused on medication safety, medical education, and advances in digital health technologies, novel therapeutics, and drug-delivery systems in the treatment of substance use disorders.

Dr. Graham is double board-certified (adult and child/adolescent) psychiatrist with expertise in young adult mental health, emergency mental health, consultation-liaison psychiatry, medical education/training, clinical informatics and medical writing/editing. She completed her psychiatry residency and child and adolescent psychiatry fellowship at UMass Chan Medical School, following which she worked as an attending psychiatrist at UMass Memorial Medical Center and an Assistant Professor of Psychiatry and Pediatrics at UMass Chan Medical School. She is currently an Associate Psychiatrist at Brigham and Women’s Hospital and a Clinical Instructor in Psychiatry at Harvard Medical School.

Dr. Graham works as a board-certified medical toxicologist and an emergency medicine physician at UMass Chan Medical School in Worcester, MA. There, he is also the director of the outpatient toxicology clinic. He acts as an educator, clinician, and researcher in these capacities. He completed his toxicology fellowship in 2022 at UMass after completing his residency in emergency medicine also at UMass. His current academic and research interests include psychedelics, addiction medicine, cannabinoids, and harm reduction.

Dr. Haroz is Associate Professor in the Department of Emergency Medicine at Cooper Medical School of Rowan University, Division Head of Toxicology and Addiction Medicine, and Medical Director at the Center for Healing. She is board certified in emergency medicine, medical toxicology, and addiction medicine, obtaining her BA in biology from Brandeis University, her MD from Tufts University and completed a residency in emergency medicine and fellowship in medical toxicology. She has spent the last 17 years working in inner city emergency departments, mostly in the Camden area where opioid intoxication, abuse and dependency are rampant. She helped build and now staffs the Outreach Clinic at the Urban Health Institute at Cooper University Hospital in Camden, New Jersey, an addiction medicine specialty clinic dedicated to treating patients with substance use disorders and helped build an integrated clinic for patients with HIV and substance use disorders. In 2016 she helped create and implement an initiative to prescribe buprenorphine from the Emergency Department and bridge patients to treatment to various community partners. In 2019 she helped launch an innovative program aimed at initiating buprenorphine via paramedics in the field. She is also heavily involved in education of residents, medical students, and pharmacists and organizes education forums focused on topics related to opioid dependency and treatment.

Dr. Andrew A. Herring graduated Bowdoin College and graduated from Harvard Medical School then completed residency in emergency medicine at Highland General Hospital—Alameda Health System in Oakland, CA where he is Chief of Addiction Medicine overseeing inpatient addiction services, emergency department based services, an outpatient addiction medicine clinic and a regional substance use disorder telemedicine hotline. Dr. Herring is board certified in Pain Medicine and the past Medical Director of the Alameda Health System Functional Restoration Pain Clinic. Dr Herring has led national efforts to transform hospital-based care for substance use disorders and his work has been featured in local and national press including the New York Times, Los Angeles Times and National Public Radio. Dr. Herring co-founded CA BRIDGE and the Bridge Center at the Public Health Institute. Dr. Herring’s research has been funded by the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute (PCORI) and has been published in numerous journals including JAMA Open and Annals of Emergency Medicine. Dr. Herring co-leads several NIDA supported clinical trials and is principal investigator for the Public Health Institute CA Bridge Outcomes Study. He has conducted migrant health research as a Fulbright Scholar in Central America and co-founded The Street Level Health Project that serves undocumented migrant workers in Oakland,CA. Dr. Herring is board-certified in Emergency Medicine, and Addiction Medicine, and Pain Medicine and is an Assistant Clinical Professor at the University of California, San Francisco.

Daniel Hryhorczuk, MD, MPH, FACMT is a Professor Emeritus of Environmental and Occupational Health Sciences and Epidemiology at the University of Illinois School of Public Health. He is the past director of the Toxikon Consortium and the Great Lakes Centers for Occupational and Environmental Safety and Health (WHO Collaborating Center). He has been working on environmental and public health issues in Ukraine for over 25 years and is an International Member of the Ukrainian Academy of Medical Sciences. He is the author of over 150 scientific publications and four novels.

I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.

Dr. Health Jolliff has more than 30 years of clinical practice and is dual board-certified in Emergency Medicine and Medical Toxicology. He is now certified as an executive coach, working with physicians in all stages of their careers. He works to help them find focus, direction and solutions to their current and future career challenges. He works as an an educator, a national speaker and has his own consulting business.

Dr. Kerns trained in Emergency Medicine and Medical Toxicology and served as Professor in both disciplines at Carolinas Medical Center for 33 years. Faculty roles included leadership of the Medical Toxicology Fellowship and clinical division, consultation for the Carolinas Poison Center, and research. Research interests included antidotes, envenomation, and resuscitation of cardiotoxic drugs. He also served the ACMT focusing on advancing research and education.

Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.

Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

>Dr. Venkat Kotamraju, MBBS, MRCSEd, FRCEM, is a Consultant in Emergency Medicine at the Royal Derby Hospital, UK, with over 20 years of experience and a distinguished career in medical education, clinical toxicology, and healthcare leadership. He serves as CESR Programme Director, Teaching Lead, and Leadership Lead for the East Midlands School of Emergency Medicine. A certified Medical Examiner and Specialist Advisor for the Care Quality Commission, Dr. Kotamraju is renowned for his expertise in emergency toxicology, actively contributing to the RCEM Toxicology Special Interest Group and MENATOX. Internationally recognized as a speaker and educator, he delivers lectures at conferences worldwide and leads ATLS courses and Royal College of Emergency Medicine preparatory training across the UK, UAE, and India. Elected Vice Chair of the Quality and Safety Special Interest Group of the International Federation of Emergency Medicine, he holds numerous certifications in patient safety and quality, reflecting his dedication to advancing emergency medicine and improving healthcare systems globally.

Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.

Jeffrey Lai, MD, is an emergency physician and medical toxicologist. He completed his undergraduate studies at the University of California, Berkeley; medical school at the University of Pittsburgh; and emergency medicine residency and medical toxicology fellowship at the University of Massachusetts. He is the program director of the medical toxicology fellowship at UMass Chan Medical School, and his academic interests include medical education, the application of novel technologies to the treatment of substance use disorders, and the surveillance of impairing substances in patients with severe traumatic injurie

Bruce Lanphear, MD, MPH, is a Professor at Simon Fraser University and a board-certified physician in public health and preventive medicine. He earned his medical degree from the University of Missouri at Kansas City and completed his residency at Tulane University School of Public Health & Tropical Medicine. He also undertook post-doctoral research training in community pediatrics at the University of Rochester. For over 30 years, Dr. Lanphear has studied the effects of toxic chemicals—such as lead, fluoride, and pesticides—on human health. His research has shaped federal standards for lead in air, water, and household dust and shown that no level of lead is safe for children or adults. He has advised the Commission for Environmental Cooperation, the U.S. Environmental Protection Agency, Health Canada, the CDC, and the American Academy of Pediatrics. He has testified before the U.S. Congress and the Canadian House of Commons on preventing lead poisoning. Dr. Lanphear has also served as an unpaid expert witness for lead-contaminated communities and in a federal case on fluoride toxicity. Together with his brother Bob, he co-founded Little Things Matter, a platform that simplifies science on toxic chemicals for the public. They produce videos to show how health is inextricably linked with toxic chemicals and pollutants, and champion population strategies to prevent disease.

Dr. Michael Lynch is an associate professor of Emergency Medicine, Toxicology, and Addiction Medicine at the University of Pittsburgh where he works clinically in several UPMC hospitals. He is currently Senior Medical Director for Quality and Substance Use Disorder Services at UPMC Health Plan. He previously served as the first Medical Director of the PA Department of Drug and Alcohol Programs and was Medical Director of the Pittsburgh Poison Center for 10 years. He is the founder and director of the UPMC Medical Toxicology Telemedicine Bridge Clinic.

Jeanna Marraffa is currently the Clinical Director of the Upstate New York Poison Center and a Clinical Professor in the Department of Emergency Medicine at Upstate Medical University, University Hospital in Syracuse, NY. She graduated from Union University, Albany College of Pharmacy with her Pharm.D. Degree in 2001 and have completed a one-year ASHP accredited Pharmacy Practice Residency at SUNY Upstate Medical University, Department of Pharmacy. She completed a 2-year Fellowship Program in Clinical Toxicology and Emergency Medicine in 2004 at the Upstate New York Poison Center, Department of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY and became a Diplomate of the American Board of Applied Toxicology in 2005. She received her Masters of Public Health in May 2020 from SUNY Albany. She has published numerous publications in the field of toxicology and have authored a book chapter in the 9th, 10th, 11th and upcoming 12th editions of Goldfrank’s Toxicologic Emergencies on “Dieting Agents”. She currently serves as president-elect for the American Academy of Clinical Toxicology.

Dr. Maskell is board certified in emergency medicine, medical toxicology, and addiction medicine.  He has an appointment as Assistant Professor of Military and Emergency Medicine at Uniformed Services University of Health Sciences and currently serves as the Medical Director of the Tactical Medicine Readiness Division at the US Army Medical Department Medical Center of Excellence, Ft. Sam Houston, Texas.  He also serves as guest faculty at Brooke Army Medical Center and as a Consulting Toxicologist for the Washington Poison Center.  He graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science, completed his Emergency Medicine residency at Madigan Army Medical Center in Tacoma, Washington, and his Medical Toxicology fellowship at Virginia Commonwealth University in Richmond, Virginia.  

Dr. Dan McCabe is a Clinical Associate Professor of Emergency Medicine and Pharmacy at the University of Iowa, Division Director of Medical Toxicology at the University of Iowa, and Medical Director for Iowa Poison Control Center.

Dr. Murphy is the current President of the Canadian Association of Poison Centres and Clinical Toxicology and Medical Director of the Atlantic Canada Poison Centre. She is an Associate Professor at Dalhousie University in the Department of Emergency Medicine. Dr. Murphy completed her medical toxicology fellowship at the University of California, San Francisco and is American Board certified in Medical Toxicology and Addiction Medicine.

Nicholas E. Nacca, MD, FACMT is an Assistant Professor of Emergency Medicine, Director of Medical Toxicology, and Associate Fellowship Director of the Medical Toxicology Fellowship Program at the University of Rochester Medical Center (URMC). In addition to his role within the Department of Emergency Medicine, Dr. Nacca holds a secondary appointment in the Department of Environmental Medicine. As Director of Medical Toxicology, Dr. Nacca oversees the educational and clinical operations of the medical toxicology consultation service, where he is actively involved in training medical toxicology fellows, as well as mentoring multidisciplinary teams that include medical residents, pharmacy residents, and medical students. He also staffs and directs a referral-based outpatient Medical Toxicology Clinic, where he provides specialized care to patients requiring toxicological evaluation and treatment. Dr. Nacca’s work bridges clinical practice and education, emphasizing the development of the next generation of toxicology professionals while providing expert consultation in both inpatient and outpatient settings.

Dr. Mykola Prodanchuk is a renowned toxicologist, professor, and doctor currently serving as Director of the L.I. Medved's Research Center of Preventive Toxicology in Kyiv, Ukraine. He has held key roles, including State Sanitary Doctor and Deputy Minister of Health, and is a member of Ukraine's Academy of Medical Science.

As a consultant to the Ukrainian Parliament and Minister of Health, he has contributed to major health policies and legislation. He has also worked with international bodies like WHO, UNEP, and the World Bank. Mykola is a member of EUROTOX, IUTOX, the Society of Toxicology of the USA, and the American Public Health Association

Dr. Kerollos Shaker is a board certified Emergency Medicine Physician and Medical Toxicologist in Houston, Texas. He graduated from University of Alabama School of Medicine. He completed residency in Emergency Medicine and fellowship in Medical Toxicology. Currently practicing as an ER Doctor and Toxicologist Consultant. He is also a Laboratory Director with experience in high-complexity labs.

Dr. Simpson is an emergency physician and medical toxicologist at Beth Israel Deaconess Medical Center. He completed his residency at Vanderbilt University Medical Center and his medical toxicology fellowship at the Harvard Medical Toxicology Fellowship. He is a current T32 fellow with the Center for Resuscitation Science at BIDMC. His research interests include prediction and management of cardiovascular toxicity in acute drug overdose as well as bupropion cardiotoxicity.

Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets. 

Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Dr. Wightman is an Assistant Professor of Emergency Medicine at Alpert Medical School of Brown University. She is a triple board-certified practicing physician in medical toxicology, addiction medicine, and emergency medicine. She serves as Director of Toxicology Education for Brown Emergency Medicine and as faculty in the Addiction Medicine Fellowship at Rhode Island Hospital. She completed medical toxicology fellowship and emergency medicine residency at New York University School of Medicine/ Bellevue Hospital Center. 

Dr. Wightman’s primary clinical expertise is in the evaluation and management of drug toxicity syndromes in complex medical patients and enhancing medication safety for high-risk drugs. Her research is focused on evaluation and tracking of emerging drug trends, cannabis hyperemesis syndrome, and medications for treatment of opioid use disorder.

Michael Yeh is a medical toxicology physician in CDC's National Center for Environmental Health (NCEH) and a Lieutenant Commander in the U.S. Public Health Service Commissioned Corps. Michael graduated with a B.S. in biology from SUNY Stony Brook, an M.S. in journalism from Columbia University, as well as an M.S. in epidemiology and M.D. from the University at Buffalo, SUNY. He completed a combined internal medicine and emergency medicine residency at Allegheny General Hospital in Pittsburgh. Prior to joining CDC, Michael worked as an emergency physician in Patchogue, NY (Long Island) and in Westerly, Rhode Island, before completing the Emory University/CDC medical toxicology fellowship in 2021. Michael's activities at CDC include working with America’s Poison Centers on surveillance of chemical exposures and public health hazards, acute toxicologic outbreak investigations, emergency preparedness for chemical and radiological disasters, and medical toxicology fellow education.

Dr. Yin currently serves as the medical director of the Cincinnati Poison Drug and Information Center where he has been since 2010. He is an associate professor of pediatrics at the University of Cincinnati School of Medicine and also works clinically as a pediatric emergency medicine attending at Cincinnati Children’s Hospital.

Dr. Yin is on the editorial board for the American Academy of Pediatrics (AAP) published journal - Pediatrics in Review and a peer reviewer for a number of pediatrics journals. He also administers and is the primary educator for a toxicology rotation for pediatric emergency medicine fellows, child abuse fellows, pediatric residents, med-peds residents, and pharmacy residents.